Radiopharmaceuticals and Tracers

This channel includes news and new technology innovations for nuclear and molecular imaging agents, radiotracers and radiopharmaceuticals used in PET or SPECT imaging. This includes advances in myocardiac perfusion agents.

News | August 09, 2013

August 9, 2013 — Positron Corporation entered into a multi-year radioisotope supply agreement with iThemba LABS of...

News | August 08, 2013

The Centers for Medicare and Medicaid Services (CMS) released its proposed decision memorandum regarding the use of...

Feature | July 26, 2013 | Jamshid Maddahi, M.D., FACC, FASNC, and René R. S. Packard, M.D.
Coronary artery disease (CAD) is a major cause of death in modern industrialized countries. Assessments of regional...
PET vs. SPECT, nuclear imaging advances with BFPET

BFPET demonstrates higher resolution in the evaluation of myocardial perfusion in this series of images contrasting the results of a PET scan done with FluoroPharma's fluorine-18 based agent and a SPECT study done with sestamibi. Images were captured during an investigator-initiated study of BFPET conducted at 301 Hospital in Beijing, China.

Feature | Nuclear Imaging | July 23, 2013 | Dave Fornell

Just when positron emission tomography (PET) appears to be eclipsing single photon emission computed tomography (...

Biopharmaceuticals Inc. Clinical Study Alzheimer's Beta Amyloig
Feature | July 12, 2013

July 12, 2013 — Biopharmaceuticals Inc. announced the first subject has been enrolled in its NAV4694 global, pivotal...

SNMMI Alzheimer's Association Medicare Decision CMS Beta Amyloid PET Coverage
Feature | July 11, 2013

July 11, 2013 — The Society of Nuclear Medicine and...

Feature | June 20, 2013

June 20, 2013 – No matter where they have hidden, metastatic prostate cancer cells still express some of the same...

Feature | June 20, 2013

June 20, 2013 — A relatively new weapon in the fight against childhood brain cancer has emerged that improves upon...

News | June 19, 2013

June 19, 2013 — Alzheimer’s disease has been linked in many studies to amyloid plaque buildup in the brain, but new...

News | June 19, 2013

June 19, 2013 — By targeting both bone cell activity and immune response and improving imaging data interpretation,...

News | June 17, 2013

June 17, 2013 — Accurate estimation of radiation absorbed dose in radioimmunotherapy (RIT) based on state-of-the-art...

News | June 05, 2013

June 5, 2013 — Highly educated individuals with mild cognitive impairment that later progressed to Alzheimer’s...

Positron Corp PosiRx 3000-Series Pharmacy Automation Systems
Technology | May 16, 2013

May 16, 2013 — Positron Corp. announced the release of the PosiRx 3000-Series, its latest pharmacy automation...

Lymphoseek
News | May 08, 2013

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of...

News | April 29, 2013

 

April 29, 2013 — Navidea Biopharmaceuticals Inc. announced the peer-reviewed publication of results from a...

Cardiolite vials
News | April 12, 2013

April 12, 2013 — Lantheus Medical Imaging has entered into a new agreement with Fujifilm RI Pharma (FRI) to license...

Chalk River Labs
News | April 08, 2013

April 8, 2013 — Atomic Energy of Canada Limited (AECL) will commence a 30-day planned shutdown for inspection and...

An FDDNP brain scan of an individual with mild cognitive impairment (MCI) illustrates the parietal and frontal regions of the brain (see arrows) that have significant relationships to cognitive function. The lateral temporal lobe was another significant region, but is not included in this brain section.

News | April 05, 2013

April 5, 2013 — UCLA researchers have used a brain-imaging tool and stroke risk assessment to identify signs of...